Now you can see non-English news...
2021-12-21T07:36:44.511Z
The French giant wants to strengthen itself in immuno-oncology. The French laboratory Sanofi announced on Tuesday that it had reached an agreement to acquire the American biotech Amunix for at least a billion dollars in order to strengthen itself in immuno-oncology. Under the terms of the deal, Sanofi will acquire Amunix for an upfront payment of $ 1 billion, along with $ 225 million in milestone payments, " depending on the achievement of certain development
The French laboratory Sanofi announced on Tuesday that it had reached an agreement to acquire the American biotech Amunix for at least a billion dollars in order to strengthen itself in immuno-oncology.
Under the terms of the deal, Sanofi will acquire Amunix for an upfront payment of $ 1 billion, along with $ 225 million in milestone payments, "
depending on the achievement of certain development goals.
", He said in a press release.
© Communities 2019 - Privacy
The information on this site is from external sources that are not under our control.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/6GEKDOLV2NGJ7PQMJUEXGFLG6Y.JPG)